Overall, cardiologists made corrections to 16.8% of AI-generated assessments and 27.2% of sonographer assessments.

The company emphasized that the issues are quite rare. No devices are being recalled, and it is not recommended that customers stop using them. 

Commissural alignment is especially important now, researchers explained, because TAVR is being recommended for younger patients with longer life expectancies. 

Medtronic launched its MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with compatible cardiac devices.

Rao spoke with Cardiovascular Business at ACC.23 to detail some of SCAI's biggest accomplishments from the last year. 

The interventional cardiologist is now working with vendor Supira Medical to help advance the company's next-generation percutaneous ventricular assist device.

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

These experiments, performed with help from NASA, are simply out of this world. 

OXOS Medical has ballooned its fundraising total to $45M, with Parkway Venture and Intel Capital leading the way, leaders announced.

Johnson & Johnson has offered to pony up $8.9 billion over 25 years to settle all current and future claims that its talc baby powder contained asbestos and caused cancer to some consumers. It is one of the largest consumer liability settlements in history.